A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study

SIMPLE SUMMARY: Soft tissue sarcomas (STS) are an uncommon and heterogeneous group of tumors, with scarce options for treatment in advanced cases. There is no consensus regarding which is the best treatment sequence for these patients. Although trabectedin is an approved drug for STS treatment, afte...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Cancers (Basel)
Κύριοι συγγραφείς: Martínez-Trufero, Javier, De Sande-González, Luis Miguel, Luna, Pablo, Martin-Broto, Javier, Álvarez, Rosa, Marquina, Gloria, Diaz-Beveridge, Roberto, Poveda, Andrés, Cano, Juana María, Cruz-Jurado, Josefina, López Pousa, Antonio, Vaz Salgado, María Angeles, Valverde-Morales, Claudia M., Sevilla, Isabel, Martínez-García, Jerónimo, Rubio-Casadevall, Jordi, De Juan, Ana, Carrasco, Juan Antonio, Moura, David S, Gurruchaga-Sotes, Ibon, Gutiérrez, Antonio
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: MDPI 2021
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7917652/
https://ncbi.nlm.nih.gov/pubmed/33672857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040792
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια